SYLLABUS
GS-3: Achievements of Indians in science & technology; indigenization of technology and developing new technology.
Context: Union Agriculture and Farmers’ Welfare Minister Shivraj Singh Chouhan dedicated India’s first indigenous H5N1 bird flu vaccine to the nation, marking a major milestone in animal healthcare and self-reliance.
About the Indigenous H5N1 Bird Flu Vaccine
- Developer: ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal, Madhya Pradesh.
- Target Disease: Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu.
- Target Strain: H5N1 virus of Clade 2.3.2.1a.
- Target Species: Chickens and poultry birds; it is not a human vaccine.
Significance of the Indigenous H5N1 Vaccine
- Disease Prevention: India has witnessed over 500 bird flu outbreaks since 2006, including around 10 lakh chicken deaths in 2006, 9 lakh in 2021 and 2 lakh in 2026.
- Farmers’ Protection: Its affordable price of ₹1–2 per dose will make vaccination accessible to small poultry farmers and help protect their livelihoods.
- Economic Security: Reduces poultry mortality and financial losses caused by bird flu outbreaks, strengthening the rural economy.
- Food Security: Helps maintain poultry production and ensures the availability of poultry products.
- Scientific Self-Reliance: Demonstrates India’s indigenous research capabilities and reduces dependence on imported animal vaccines.
- Research Infrastructure: The proposed ₹300-crore animal disease research laboratory in Bhopal will strengthen research, disease surveillance and preparedness against emerging animal diseases.
About the Influenza A Virus
- Influenza A is a type of influenza virus that infects humans and various animal species, including birds and mammals.
- It is responsible for seasonal influenza outbreaks and occasional pandemics.
- It is classified into subtypes based on two surface proteins: Haemagglutinin (H) and Neuraminidase (N).
- Examples include H1N1, H3N2 and H5N1.
About the Subtype H5N1 (A/H5N1)
- H5N1 is a subtype of the Influenza A virus that causes Avian Influenza, commonly known as bird flu.
- First Identification: Identified in farmed geese in southern China in 1996.
- Transmission: Spreads through infected birds’ saliva, mucus and faeces. It can also spread to mammals through exposure to infected animals or contaminated environments.
- Human Infection: Rarely infects humans, mainly through close contact with infected birds or animals. Sustained human-to-human transmission has not been reported.
- Symptoms in Birds: Respiratory distress, swollen head, watery eyes, reduced egg production and sudden death.
- Symptoms in Humans: Fever, cough, diarrhoea and respiratory illness. Severe cases may cause pneumonia and death.
- Classification: Avian influenza is classified as Low Pathogenic Avian Influenza (LPAI) or Highly Pathogenic Avian Influenza (HPAI), based on its pathogenicity in domestic chickens.
Government Initiatives for Animal Disease Control
- National Animal Disease Control Programme (NADCP): Launched to control Foot and Mouth Disease and Brucellosis through vaccination.
- FMD Vaccination: 147.16 crore free vaccine doses have been administered under the programme.
- Lumpi-ProVacInd: Indigenous vaccine developed by scientists at Hisar and Izatnagar to combat Lumpy Skin Disease.
- ICAR-NIHSAD: Developed indigenous vaccines for Gumboro disease, Brucella abortus S-19 Delta, Classical Swine Fever and African Swine Fever.
